HAMP and acute kidney injury: Patients with subclinical AKI (NGAL/hepcidin-25 ratio ≥ 0.5 but no KDIGO-AKI) had a 23-fold increased risk of in-hospital mortality compared with patients without AKI, almost seven times greater than clinical AKI (Fig. 1).